Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (4)

1

Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C

enthalten in: Terapevticheskii arkhiv | 2022

von Grushko, I. | Romanova, E. | Tverdokhlebova, T. | +2

2

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C

in: Российский журнал гастроэнтерологии, гепатологии, колопроктологии | 2020

von P. O. Bogomolov | A. O. Bueverov | V. E. Bakirova | +4

3

ACUTE HEPATITIS С ON THE BACKGROUND OF LIVER Cirrhosis IN THE OUTCOME OF CHRONIC HEPATITIS C: CLINICAL CASE

in: Медицинский совет | 2018

von V. G. Morozov | E. S. Malova | L. M. Topornina | +6

4

Combined use of direct antiviral drugs - paritrapevir, ritonavir, ombitasvir and dasabuvir in the treatment of patients with HCV-deterministic compensated cirrhosis in real clinical practice

in: Медицинский вестник Юга России | 2018

von Yu. M. Ambalov | A. P. Kovalenko | O. A. Pshenetskaya | +1

1
[1]